Technical Analysis for SVA - Sinovac Biotech, Ltd. (Antigua/Barbudo)

Grade Last Price % Change Price Change
grade F 6.47 0.31% 0.02
SVA closed up 0.31 percent on Thursday, January 17, 2019, on 28 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical SVA trend table...

Date Alert Name Type % Chg
Jan 17 20 DMA Resistance Bearish 0.00%
Jan 17 Shooting Star Candlestick Bearish 0.00%
Jan 17 1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 17 Stochastic Reached Oversold Weakness 0.00%
Jan 17 Outside Day Range Expansion 0.00%
Jan 17 Oversold Stochastic Weakness 0.00%
Jan 16 Outside Day Range Expansion 0.31%
Jan 15 Narrow Range Bar Range Contraction -0.61%
Jan 15 NR7 Range Contraction -0.61%

Older signals for SVA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines for hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. Its products include Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a split viron influenza vaccine; Panflu, a vaccine against the H5N1 influenza virus; Panflu.1, a vaccine against the influenza A H1N1 virus; mumps vaccine; split viron pandemic influenza vaccine; and RabEnd, a animal rabies vaccine. The company has also completed a phase I clinical trial of a SARS vaccine. In addition, it develops the EV71 vaccine, which has completed clinical trials. Further, the company develops a pipeline of vaccine candidates in the clinical and pre-clinical development phases, including human vaccines for pneumococcal, rotavirus, rabies, varicella, and rubella that are in pre-clinical stage. It has a collaboration agreement with Tianjing CanSino Biotechnology Inc. to develop a pneumococcal vaccine; and a license agreement with Medimmune, LLC to use patented reverse genetics technology pertaining to virus strain production for vaccines, including the H5N1 influenza virus strain. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the People's Republic of China.
Is SVA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 8.75
52 Week Low 5.73
Average Volume 20,430
200-Day Moving Average 7.4121
50-Day Moving Average 7.0874
20-Day Moving Average 6.6965
10-Day Moving Average 6.676
Average True Range 0.2834
ADX 46.31
+DI 12.6037
-DI 28.6254
Chandelier Exit (Long, 3 ATRs ) 6.2498
Chandelier Exit (Short, 3 ATRs ) 6.5802
Upper Bollinger Band 7.2976
Lower Bollinger Band 6.0954
Percent B (%b) 0.31
BandWidth 17.952662
MACD Line -0.15
MACD Signal Line -0.1274
MACD Histogram -0.0226
Fundamentals Value
Market Cap 368.59 Million
Num Shares 57 Million
EPS -0.08
Price-to-Earnings (P/E) Ratio -80.88
Price-to-Sales 6.26
Price-to-Book 3.48
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.00
Resistance 3 (R3) 7.04 6.91 6.91
Resistance 2 (R2) 6.91 6.78 6.89 6.88
Resistance 1 (R1) 6.69 6.69 6.80 6.65 6.85
Pivot Point 6.56 6.56 6.62 6.54 6.56
Support 1 (S1) 6.34 6.43 6.45 6.30 6.09
Support 2 (S2) 6.21 6.34 6.19 6.06
Support 3 (S3) 5.99 6.21 6.03
Support 4 (S4) 5.95